Alexander Ditchfield
Managing Director, Head of New York
뉴욕
Alexander Ditchfield is a Managing Director and Head of BDA’s New York office. Clients for whom he has advised on transactions include Aterian Investment Partners, CHS, CITIC Capital, Kerry, Littlejohn, On Semi, MacLean-Fogg, Molex, and Pfizer, among others.
Prior to moving to New York in 2016, he worked in BDA’s Shanghai and Hong Kong offices for seven years. He speaks Mandarin and English.
Recent transactions
acquired majority stake in
2024
헬스케어
received investment from
2023
산업재
a portfolio company of
has been sold to
2023
산업재
divested Niigata fab to
Sangyo Sosei and Fukuoka Capital
2022
산업재
acquired by
a portfolio company of
2022
화학
has been acquired by
2022
테크놀로지
divested ASG Print to
and
2021
산업재
has been acquired by
2021
화학
divested China phenolic resins plant to
2021
화학
divested to
a portfolio company of
2020
화학
Presswerk Krefeld a portfolio company of
has been acquired by
2017
산업재
raised equity capital and new Asian partnerships
2016
화학
CHS Ningbo Protein Foods a subsidiary of CHS has been acquired by
Shandong Wonderful
2016
소비재
a portfolio company of
has been acquired by
2016
산업재
divested
to
2014
산업재
divested
to American Tire Distributors
2014
산업재
divested KDM to Superior Capital Partners / Nelson-Miller
2012
산업재